Ads
related to: multiple myeloma- Contact a Representative
For Questions and Information
About This Treatment
- Primary and Subgroup Data
Primary- and Subgroup-
Specific Data
- Phase 3 Trial
Explore the Phase 3 Trial Design,
Results, and Patient Population
- Patient Profile
Potential Treatment Candidates
HCPs, See Who May Be Appropriate
- Contact a Representative
Search results
Questions About Melanoma? Harvard Health Publishing Has Answers.
MSN News· 2 days agoWhat are the early stages of melanoma? Answered by Dr. Howard E. Lewine M.D. Chief Medical Editor,...
'Smart warheads' of cancer: Experts' excitement for treatment approach grows
Becker’s Hospital Review· 21 hours agoCancer experts are increasingly optimistic about the potential for antibody-drug conjugates to become a standard treatment approach. The therapies involve attaching chemotherapy to an antibody ...
Monoclonal Antibody May Benefit Patients With Kidney Transplant Rejection
MedPage Today· 7 days agoOriginally developed for multiple myeloma, felzartamab is a fully human IgG1 monoclonal CD38...
3 High-Yielding Dividend Stocks On Euronext Paris With Up To 4.2% Yield
Simply Wall St. via Yahoo Finance· 6 days agoIn recent trading sessions, France's CAC 40 Index has experienced a modest decline of 0.89%,...
J&J gains another bispecific antibody with $1.25B skin drug buy
BioPharma Dive via Yahoo Finance· 7 days agoJ&J has also made clear its interest in bispecific antibodies, medicines that simultaneously home in...
Karyopharm to Participate at the Jefferies Global Healthcare Conference
WROC Rochester· 5 days agoKaryopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate ...
Obesity and Cancer: Untangling a Complex Web
Medscape· 7 days agoAccording to the Centers for Disease Control and Prevention (CDC), over 684,000 Americans are diagnosed with an "obesity-associated" cancer each year....
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with...
The Sun Chronicle· 2 days agoKaryopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the presentation of updated exploratory subgroup analyses ...
Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse
KOLR - KSFX Ozarks· 3 days agoImmunocan announces significant progress in the construction of its alpaca-derived nanobody discovery platform, ImmuAlpaca® mouse. The IGH-VDJ genes in the mouse genome have been successfully ...
Markey Cancer Center holds tenth annual ‘Expressions of Courage’
WKYT Lexington· 3 days agoLEXINGTON, Ky. (WKYT) -Markey Cancer Center celebrated their tenth annual “Expressions of Courage”...
Ad
related to: multiple myeloma
